Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

2025-04-09 15:59:57 ET

Summary

• The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally.
• Despite pledges to increase U.S. manufacturing, companies like Eli Lilly and Novo Nordisk are suffering substantial share price declines.
• The feasibility of relocating drug manufacturing to the U.S. is highly questionable, potentially leading to drug shortages and higher domestic prices.
• Investors should be cautious; Pharma valuations may continue to fall, and the broader market is also under pressure due to tariff uncertainties.

Investment Overview

The Trump administration's imposition of tariffs on goods imported into the U.S. has sent shockwaves across the globe and created turmoil across most if not all, stock markets around the world.

The S&P 500 ( SPX ) is down nearly 10% across the past 5 days and down >15% year-to-date, its biggest crash since the COVID pandemic was declared in early 2020. President Trump is apparently in no mood to back down. However, despite rapid retaliation from countries globally to his own retaliatory or "reciprocal" tariffs....

Read the full article on Seeking Alpha

For further details see: